Sia A T
Department of Anaesthesia, KK Women's and Children's Hospital, Singapore, Singapore.
Can J Anaesth. 2000 Sep;47(9):875-80. doi: 10.1007/BF03019667.
The combination of intrathecal (IT) 5 microg sufentanil plus 1.25 mg bupivacaine is useful for inducing labour analgesia, albeit of short duration and slow onset. As a supplementation to this regimen, the effect of IT clonidine on the duration of analgesic action was investigated.
Forty-eight healthy parturients were randomly assigned into three groups to receive 0 microg (group C0), 15 microg (C15) or 30 microg (C30) of clonidine IT in addition to 5 microg sufentanil plus 1.25 mg bupivacaine IT for labour analgesia. The quality of pain relief was assessed on 0-100 visual analogue scale by the author. The occurrence of side effects was also evaluated before the request for additional analgesia.
Clonidine (C15 and C30), produced a longer duration of analgesia than C0 (mean 144 +/- sd 27.9, 165 +/- 31.8 vs 111 +/- 21.9 min, P < 0.01). Also, C15 and C30 produced a more rapid onset and a higher quality of analgesia than C0, (P < 0.01). The most cephalad level of sensory block was higher in C30 than C15 (median T3 vs T4, P < 0.05) but lowest in C0 (median T7 vs T3,T4, P < 0.01). Side effects, sedation and hypotension, occurred more frequently in C30 than in either C0 or C 15, (9 vs 2,5 and 9 vs 1,3, respectively, P < 0.05).
The optimal dose of intrathecal clonidine to enhance labour analgesia with the current sufentanil-bupivacaine regimen is 15 microg. In view of the side effect profile, doses greater than 30 microg clonidine are unlikely to be useful.
鞘内注射(IT)5微克舒芬太尼加1.25毫克布比卡因可用于分娩镇痛,尽管持续时间短且起效缓慢。作为该方案的补充,研究了鞘内注射可乐定对镇痛作用持续时间的影响。
48名健康产妇被随机分为三组,除接受5微克舒芬太尼加1.25毫克布比卡因鞘内注射用于分娩镇痛外,分别额外接受0微克(C0组)、15微克(C15组)或30微克(C30组)鞘内可乐定注射。作者采用0-100视觉模拟评分法评估疼痛缓解质量。在要求追加镇痛前还评估了副作用的发生情况。
可乐定(C15组和C30组)的镇痛持续时间长于C0组(平均分别为144±标准差27.9、165±31.8分钟,对比111±21.9分钟,P<0.01)。此外,C15组和C30组的起效更快,镇痛质量更高,优于C0组(P<0.01)。C30组感觉阻滞的最高平面高于C15组(中位数分别为T3和T4,P<0.05),而C0组最低(中位数为T7,对比T3、T4,P<0.01)。副作用,即镇静和低血压,在C30组的发生频率高于C0组或C15组(分别为9例对比2例、5例以及9例对比1例、3例,P<0.05)。
在当前舒芬太尼-布比卡因方案中,鞘内注射可乐定增强分娩镇痛的最佳剂量为15微克。鉴于副作用情况,大于30微克可乐定的剂量可能无效。